Drew Sansone

Drew SansoneChief Regulatory Officer

Drew Sansone serves as Chief Regulatory Officer at Tango. Drew brings over 25 years of pharmaceutical regulatory experience, having served at both large, multinational pharmaceutical companies and biotech companies, with expertise across a myriad of regulatory affairs and leadership aspects. Most recently, Drew served as Vice President and Head, Global Regulatory Affairs, Regulatory and Quality at Ipsen North America. Earlier, he held a variety of regulatory affairs roles of increasing responsibility at AbbVie, Tengion, Inc., Vicuron Pharmaceuticals (acquired by Pfizer, Inc. in June 2005) and AstraZeneca, Inc.

Drew earned his Master of Science in Regulatory Affairs/Quality Assurance from Temple University and his Bachelor of Arts in Psychology and Business Administration from Sienna College.